These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23894097)

  • 41. Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.
    Taylor SJ; Abeywardane A; Liang S; Muegge I; Padyana AK; Xiong Z; Hill-Drzewi M; Farmer B; Li X; Collins B; Li JX; Heim-Riether A; Proudfoot J; Zhang Q; Goldberg D; Zuvela-Jelaska L; Zaher H; Li J; Farrow NA
    J Med Chem; 2011 Dec; 54(23):8174-87. PubMed ID: 22017539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of an exosite binding inhibitor of matrix metalloproteinase 13.
    Gooljarsingh LT; Lakdawala A; Coppo F; Luo L; Fields GB; Tummino PJ; Gontarek RR
    Protein Sci; 2008 Jan; 17(1):66-71. PubMed ID: 18042679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
    Adhikari N; Mukherjee A; Saha A; Jha T
    Eur J Med Chem; 2017 Mar; 129():72-109. PubMed ID: 28219048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.
    Kalva S; Agrawal N; Skelton AA; Saleena LM
    Mol Biosyst; 2016 Jul; 12(8):2519-31. PubMed ID: 27250644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of
    Cuffaro D; Gimeno A; Bernardoni BL; Di Leo R; Pujadas G; Garcia-Vallvé S; Nencetti S; Rossello A; Nuti E
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.
    Ndinguri MW; Bhowmick M; Tokmina-Roszyk D; Robichaud TK; Fields GB
    Molecules; 2012 Nov; 17(12):14230-48. PubMed ID: 23201642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series.
    Mary A; Renko DZ; Guillou C; Thal C
    Bioorg Med Chem; 1998 Oct; 6(10):1835-50. PubMed ID: 9839013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.
    Arkadash V; Yosef G; Shirian J; Cohen I; Horev Y; Grossman M; Sagi I; Radisky ES; Shifman JM; Papo N
    J Biol Chem; 2017 Feb; 292(8):3481-3495. PubMed ID: 28087697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach.
    Nara H; Kaieda A; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    J Med Chem; 2017 Jan; 60(2):608-626. PubMed ID: 27966948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validating the 1,2-Difluoro Motif As a Hybrid Bioisostere of CF
    Erdeljac N; Thiehoff C; Jumde RP; Daniliuc CG; Höppner S; Faust A; Hirsch AKH; Gilmour R
    J Med Chem; 2020 Jun; 63(11):6225-6237. PubMed ID: 32379447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An integrated structure- and pharmacophore-based MMP-12 virtual screening.
    Ramezani M; Shamsara J
    Mol Divers; 2018 May; 22(2):383-395. PubMed ID: 29423648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of highly potent and selective MMP2 inhibitors addressing the S1' subsite with d-proline-based compounds.
    Lenci E; Innocenti R; Di Francescantonio T; Menchi G; Bianchini F; Contini A; Trabocchi A
    Bioorg Med Chem; 2019 May; 27(9):1891-1902. PubMed ID: 30926311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach.
    Nara H; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    J Med Chem; 2014 Nov; 57(21):8886-902. PubMed ID: 25264600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Docking analysis of a series of benzylamino acetylcholinesterase inhibitors with a phthalimide, benzoyl, or indanone moiety.
    Yamamoto Y; Ishihara Y; Kuntz ID
    J Med Chem; 1994 Sep; 37(19):3141-53. PubMed ID: 7932538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.
    Heim-Riether A; Taylor SJ; Liang S; Gao DA; Xiong Z; Michael August E; Collins BK; Farmer BT; Haverty K; Hill-Drzewi M; Junker HD; Mariana Margarit S; Moss N; Neumann T; Proudfoot JR; Keenan LS; Sekul R; Zhang Q; Li J; Farrow NA
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5321-4. PubMed ID: 19692239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.
    Fischer T; Riedl R
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31216704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ligand-based design of anticancer MMP2 inhibitors: a review.
    Sanyal S; Amin SA; Adhikari N; Jha T
    Future Med Chem; 2021 Nov; 13(22):1987-2013. PubMed ID: 34634916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and Structural Evolution of Matrix Metalloproteinase Inhibitors.
    Fischer T; Senn N; Riedl R
    Chemistry; 2019 Jun; 25(34):7960-7980. PubMed ID: 30720221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.
    Hanessian S; MacKay DB; Moitessier N
    J Med Chem; 2001 Sep; 44(19):3074-82. PubMed ID: 11543676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity.
    Rouanet-Mehouas C; Czarny B; Beau F; Cassar-Lajeunesse E; Stura EA; Dive V; Devel L
    J Med Chem; 2017 Jan; 60(1):403-414. PubMed ID: 27996256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.